Healthcare
APAC healthcare deal value dropped 29% to $11.5b in 2019
APAC healthcare deal value dropped 29% to $11.5b in 2019
The total deal size in Southeast Asia surged to $2.4b.
Chart of the Day: Singapore amongst top countries with highest coronavirus recovery rate
A total of 93 cases have fully recovered from the disease.
Rubber glove makers' returns up 28.7% in 2020 YTD
UG Healthcare leads the pack with a total return of 57.1%.
Headwinds in pharma industry could hurt revenues
Companies face challenges in clinical trials and intellectual property.
Daily Briefing: 5G spectrum to be awarded mid-2020; Health insurance startup CXA Group slashes headcount
And tourism marketing will be bolstered by the government.
Haw Par's net profits inch up 1.8% to $182m in 2019
Revenue increased 2.6% to $243m due to higher healthcare arm sales in H1 2019.
Biotech firm's COVID-19 detection kit greenlighted for launch
It can now be used directly by laboratories or hospitals to test patients for clinical diagnosis.
SPH buys six aged care assets in Canada for $244.5m
This marks the company’s entry to the North American market.
AXA rolls out COVID-19 care package
Customers hospitalised due to the virus will receive $200 per day.
Raffles Medical ramps up services amidst COVID-19 outbreak
A virus kit with masks, sanitisers, and vitamins can be ordered online.
Medical inflation to rise 9.3% in 2020
Singapore’s demand for health care services continues to outstrip supply.
Raffles Medical's profit dropped 15.2% to $60.27m in 2019
Profits were hit by gestation loss for Raffles Hospital Chongqing.
SPH buys five aged care properties for $65.8m
The assets have a total capacity of 365 beds.
OUE Lippo Healthcare reversed to $3.24m profit in 2019
The inclusion of its interest in First REIT boosted the profits from its investees.
Singapore to invest $800m in fight against COVID-19
A bulk of this allocation will go to the country’s health ministry.
Alliance Healthcare Group's H2 profit surged 196.1% YoY to $1.6m
Revenues from all business segments rose.
Thomson Medical's profits rose 39.5% in Q4 to $4.2m
Profits grew due to the absence of impairment loss on development and investment properties.
Commentary
Singapore’s family offices: Time to professionalise or risk falling behind
Liquidity crucial to stock market reform